What were the key takeaways from Health In Tech's earnings call?

What is Health In Tech's gross profit margin?

What is Health In Tech's latest dividend and current dividend yield?

What were the key takeaways from Health In Tech’s earnings call?

What factors drove the changes in Health In Tech's revenue and profit?

What is the revenue and EPS growth rate for Health In Tech year over year?

What does Health In Tech do and what are its main business segments?

Did Health In Tech beat or miss consensus estimates last quarter?

- **Revenue Growth Accelerates**: Q3 2025 revenue up 90% YoY to $8.5M, 9-month total surpasses 2024 full year by 33%.
- **Market Expansion**: 849 partners (57% YoY) drive 25,240 enrolled employees, +7,654 YoY.
- **Innovative Products Launching**: 3-year rate hold program pilot begins Q4, blockchain claims platform HITChain in development.
- **Financial Strength**: 9-month EBITDA $3.8M (167% YoY), cash reserves $8M.
- **Strategic Events**: Davos InsurTech Summit 2026 to showcase AI and blockchain leadership.

**【CEO Summary Section】**
- Q3 2025 revenue reached $8.5 million, up 90% YoY, with 9-month total of $25.8 million (vs. $19.5M in 2024 full year). 
- Expanded to 849 partners (57% YoY growth), driving 25,240 enrolled employees (7,654 YoY increase).
- Launched large employer underwriting capability, enabling quotes for groups >150 employees in 2 weeks vs. industry norm of 3 months.
- Announced 3-year rate hold program pilot in Q4, offering fixed remittance model backed by A-rated carrier.
- Signed LOI with AlphaTON to develop HITChain, blockchain claims processing platform targeting $300B annual admin cost savings.
- Will host InsurTech Summit at Davos 2026, featuring AI, blockchain, and women's leadership panels.

**【CFO Financial Commentary】**
- Q3 2025: Adjusted EBITDA $1M (49% YoY growth), operating expenses $3.7M (55% of rev vs. 68% YoY). 
- 9-month EBITDA $3.8M (167% of 2024 full year), pretax income $2.1M (2.4x 2024). 
- Q4 2025 revenue expected +50% YoY, full year 2025 guidance $32-33M (70% YoY growth). 
- HITChain development capitalized, reducing R&D expenses to 2.8% of rev (vs. 16% YoY). 
- $8M cash on hand, with AlphaTON contributing capital for blockchain deployment.

**【Q&A Highlights】**
- Large employer underwriting quotes increased from 2/day to 5/day, but full impact delayed due to 60-90 day implementation cycle.
- 3-year rate hold program requires 150+ employees, targeting municipalities and government entities with tight budgets.
- HITChain blockchain claims processing will be first decentralized platform at scale, with de-identified health records and no compliance risks.
- Broker relationships deepened through regional training and pilot programs, with 849 partners now actively using eDIYBS platform.


Health In Tech, Inc. (HIT) Q3 2025 Earnings Call Transcript

- **Revenue surge**: Q2 $9.3M (86% YoY), first half 89% of 2024 total. 
- **Partnership expansion**: 778 partners, 24,839 enrolled employees (30% growth). 
- **AI platform impact**: 2-minute plan creation, 5-day underwriting vs. 14 days. 
- **Financial strength**: $8.1M cash, $2.8M EBITDA (134% YoY). 
- **Growth catalysts**: Off-season sales, mid-sized employer partnerships, HiCard Q1 2026 launch.

**【CEO Summary Section】**
- Q2 2025 revenue: $9.3 million (86% YoY growth), first half: $17.3 million (89% of 2024 total). 
- 778 partners (87% YoY increase), 24,839 billed enrolled employees (30% YoY growth). 
- Enhanced eDiP platform launching Q3; new product beta tests Q3. 
- Key partnerships: Vertigard (MedImpact PBM), Unified Health Plans (schools), Hillb Group (national broker). 
- Fully insured groups can switch plans year-round, driving off-season sales. 

**【Chief Growth Officer Summary】**
- Brokers use AI platform to create custom plans in 2 minutes, reducing costs for small businesses. 
- Vertigard partnership provides $40B in drug transactions, lowering costs. 
- Unified Health Plans targeting schools; Hillb Group expanding reach to 125 locations. 
- 14+ 100+ life cases in July, up from small group focus. 

**【CFO Financial Commentary】**
- Q2 GAAP revenue: $9.3M; first half: $17.3M (89% of 2024). 
- Adjusted EBITDA: $2.8M (134% YoY), pretax income: $1.5M (1.7x 2024 full year). 
- Sales & marketing: 13.2% of revenue (6.3% YoY decline). 
- Cash: $8.1M; positive cash flow from operations: $1.5M (Q2). 
- Accounts receivable: $1.3M (12% YoY decline vs. 86% revenue growth). 

**【Q&A Highlights】**
- **Partnership traction**: Brokers bring mid-sized employers (100-300 lives) due to platform efficiency. 
- **AI underwriting**: 5-day process vs. 14 days, attracting self-funded groups. 
- **HiCard launch**: Beta testing Q3, revenue expected Q1 2026. 
- **Market opportunity**: 60M small business employees, <0.001% penetrated. 
- **Uncertainty advantage**: ACA rate hikes (26-30%) create opening for cost-effective solutions.

Health In Tech, Inc. (HIT) Q2 2025 Earnings Call Transcript

- **Revenue Growth**: $8M Q1 revenue (+56% YoY), 257% increase in pre-tax income, 17% rise in enrolled employees.
- **AI Platform Impact**: Beta testing shows 70-80% time reduction in underwriting; full rollout in Q3 for large groups.
- **Financial Strength**: 66.8% gross margin, $1.2M adjusted EBITDA (double YoY), $7.6M cash reserves.
- **Strategic Expansion**: 459 active brokers (+135% YoY), DialCare telehealth partnership, Board addition for growth.

**【CEO Summary Section】**
- Q1 2025 revenue reached $8 million, up 56% YoY, with income before tax at $0.7 million (257% YoY growth). Enrolled employees rose to 24,307 (+17% YoY). 
- Launched beta testing for AI-backed underwriting for large groups (150+ employees), with successful cases for 1,000+ employee employers. Full rollout planned for Q3 2025.
- Collaborated with DialCare to integrate telehealth services, enhancing healthcare plan offerings.
- Broker network expanded to 459 active partners (+135% YoY), focusing on high-performing digital-first brokers.
- Appointed Sanjay Shrestha to Board of Directors for strategic growth and capital markets expertise.

**【CFO Financial Commentary】**
- Gross margin maintained at 66.8%, driven by fee-based revenue growth (69.5% YoY) and underwriting revenue (31.8% YoY).
- Operating expenses as % of revenue decreased to 61% (from 74% YoY), with adjusted EBITDA doubling to $1.2 million.
- $7.6 million cash reserves and 28-day average collection period reflect strong financial discipline.
- Shift to channel distribution model reduced sales & marketing expenses as % of revenue to 13.6% (from 20.4% YoY).

**【Q&A Highlights】**
- AI underwriting beta testing shows 70-80% reduction in underwriting time (2-3 months → ~1 month).
- Large employers (150+ employees) typically self-fund (~90%+ market), but HIT's AI platform addresses inefficiencies in underwriting process.
- Program fee revenue growth reflects employers' willingness to pay for enhanced benefits and network access.
- Channel partners drive customer acquisition, minimizing direct sales expenses.
- DialCare integration provides on-demand virtual care, aligning with employer demand for comprehensive health solutions.

Health In Tech, Inc. (HIT) Q1 2025 Earnings Call Transcript

- **Revenue Growth**: Q1 2025 revenue up 50% YoY to $5.7M, driven by mid-sized business expansion and program fee increases.
- **AI Innovation**: New underwriting platform reduces processing time from 3 months to 2 minutes, on track for full launch in 2025.
- **Financial Strength**: $7.8M cash, no debt, and 240% YoY increase in liquidity post-IPO.
- **Market Leadership**: 2-minute quoting vs. industry standard 14 days, capturing $242B self-funded healthcare market (5.4% CAGR).

**【CEO Opening Remarks】**
- **2024 Strategic Investments**: Completed IPO, expanded IT infrastructure, introduced Spec & Agg products, and launched large-group underwriting beta in Q4 2024.
- **2025 Growth Momentum**: Q1 2025 unaudited revenue of $5.7M (50% YoY growth), driven by new mid-sized business underwriting platform and program fee expansion.
- **Leadership Expansion**: Hired COO, CMO, CISO, and CCO with decades of experience in healthcare, cybersecurity, and SaaS.
- **Market Opportunity**: Addressing $6T healthcare market with AI-driven underwriting platform, reducing quoting time from 14 days to 2 minutes.

**【CFO Financial Highlights】**
- **Q4 2024 Results**: 
  - Revenue: $4.9M (down 6% YoY due to A-rated carrier shift)
  - Gross Margin: 77.4% (down 4.4pts YoY due to partner fees)
  - Operating Expenses: $4.1M (up 46% YoY due to personnel expansion)
  - Adjusted EBITDA: $0.5M (down 50% YoY)
- **Full Year 2024**: 
  - Revenue: $19.5M (up 1.8% YoY)
  - Gross Margin: 79.2% (down 8.8pts YoY)
  - Cash: $7.8M (up 240% YoY)
  - Liabilities: $2.6M (down 52% YoY)

**【Q&A Key Takeaways】**
- **AI Adoption**: Proprietary risk-scoring model with 3rd-party AI reduces underwriting time from 3 months to 2 minutes.
- **Customer Growth**: 50% YoY revenue growth in Q1 2025 driven by mid-sized businesses (150+ employees) and A-rated carrier program fees.
- **Financial Health**: $7M cash, 29-day AR turnover, no debt, and 50%+ revenue growth in first two months of 2025.
- **Shareholder Response**: Management committed to transparency despite recent stock volatility, with Q1 2025 results to be reported shortly.

HIT

HIT fundamentals

Earnings Call

You can ask Aime